LifeCord
Transfemoral Mitral Chordal Repair System
StartupLifeCord is a Or Yehuda-based startup in the Health Tech & Life Sciences sector, established in 2023. Transfemoral Mitral Chordal Repair System. The company has raised a total of $1.3M across 1 funding round, currently at the Seed stage. Key investors include MEDX Xelerator. The company has 1-10 employees.
With $1.3M in total funding, LifeCord is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2C business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2C
- Employees1-10
- HQOr Yehuda
- DistrictCenter District
- Last Round$1.3M
- MEDX Xelerator
1 article covered by sources including www.calcalistech.com.
What does LifeCord do?
LifeCord develops a Transfemoral Mitral Chordal Repair system, addressing the significant challenge of mitral regurgitation.
How much funding has LifeCord raised?
LifeCord has raised $1.3M in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include MEDX Xelerator.
What sector is LifeCord in?
LifeCord operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is LifeCord located?
LifeCord is based in Ariel Sharon Blvd 8, Or Yehuda, Israel, Center District.